CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company’s business at two upcoming investor conferences being held next week:
- The Rodman & Renshaw 14th Annual Healthcare Conference in New York City. Dr. Berger’s presentation is on Monday, September 10 at 12:05 p.m. (ET)
- The Morgan Stanley Global Healthcare Conference in New York City. Dr. Berger’s presentation is on Tuesday, September 11 at 3:00 p.m. (ET)
Both presentations will be webcast live and can be accessed by visiting the investor relations section of the Company's website at http://www.ariad.com/investor. A replay of the presentation will also be available and archived on the site for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc. is an emerging global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. ARIAD’s approach to structure-based drug design has led to several internally discovered, molecularly targeted product candidates for drug-resistant or difficult-to-treat cancers, including certain forms of chronic myeloid leukemia and non-small cell lung cancer. For additional information, visit http://www.ariad.com or follow ARIAD on Twitter (@ARIADPharm).